← FDA Drug Approvals (Drugs@FDA)
SUMATRIPTAN; NAPROXEN SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: DR REDDYS LABS LTD · Approved 2011-01-20
Drug application
- FDA Application #
ANDA090930- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SUMATRIPTAN; NAPROXEN SODIUM
- Generic name
- Sumatriptan
- Active ingredients
- SUMATRIPTAN; NAPROXEN SODIUM
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- DR REDDYS LABS LTD
- First approval
- 2011-01-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown